Cost minimalisation analysis of average acute hospital infections treatment with targocid (Teicoplanin) or vancomycine from service-provider perspective in Poland

被引：0
|
作者：
Kawalec, P.
Lis, J.
机构：
[1] Centrum HTA, Krakow, Poland
[2] Sanofi Aventis, Warsaw, Poland
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63514-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A302 / A302
页数：1
相关论文
共 29 条
  • [1] Teleradiology from the provider’s perspective—cost analysis for a mid-size university hospital
    Christian Rosenberg
    Kristin Kroos
    Britta Rosenberg
    Norbert Hosten
    Steffen Flessa
    European Radiology, 2013, 23 : 2197 - 2205
  • [2] Teleradiology from the provider's perspective-cost analysis for a mid-size university hospital
    Rosenberg, Christian
    Kroos, Kristin
    Rosenberg, Britta
    Hosten, Norbert
    Flessa, Steffen
    EUROPEAN RADIOLOGY, 2013, 23 (08) : 2197 - 2205
  • [3] Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in patients with acute coronary syndrome in Poland - Modelling study from the hospital perspective
    Orlewska, E
    Budaj, A
    Tereszkowski-Kaminski, D
    PHARMACOECONOMICS, 2003, 21 (10) : 737 - 748
  • [4] Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
    Daniela Zinzi
    Ioanna Vlachaki
    Edel Falla
    Theo Mantopoulos
    Dilip Nathwani
    The European Journal of Health Economics, 2022, 23 : 1371 - 1381
  • [5] Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
    Zinzi, Daniela
    Vlachaki, Ioanna
    Falla, Edel
    Mantopoulos, Theo
    Nathwani, Dilip
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2022, 23 (08): : 1371 - 1381
  • [6] Implementation of an acute care emergency surgical service: a cost analysis from the surgeon's perspective
    Anantha, Ram Venkatesh
    Parry, Neil
    Vogt, Kelly
    Jain, Vipan
    Crawford, Silvie
    Leslie, Ken
    CANADIAN JOURNAL OF SURGERY, 2014, 57 (02) : E9 - E14
  • [7] BUDGET IMPACT ANALYSIS OF ORITAVANCIN FOR THE TREATMENT OF MODERATE TO SEVERE ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) FROM A HOSPITAL PERSPECTIVE
    Garg, M.
    Venugopalan, V.
    Premraj, S.
    Park, H.
    VALUE IN HEALTH, 2018, 21 : S151 - S151
  • [8] Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: A Canadian hospital perspective
    Marra, FO
    Frighetto, LO
    Marra, CA
    Sleigh, KM
    Stiver, HG
    Bryce, EA
    Reynolds, RP
    Jewesson, PJ
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) : 156 - 162
  • [9] USE OF DALBAVANCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS
    Hernandez, I
    Carcedo, D.
    Sabaniego, J.
    Rossello, I
    Jimenez, A.
    VALUE IN HEALTH, 2022, 25 (12) : S188 - S188
  • [10] Cost analysis of the impact of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura from a US hospital perspective
    Pollissard, Laurence
    Leinwand, Brian, I
    Fournier, Marie
    Pham, Huy P.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1178 - 1184
123